Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 03, 2021

SELL
$216.38 - $257.67 $6.49 Million - $7.73 Million
-30,000 Closed
0 $0
Q3 2020

Nov 03, 2020

BUY
$234.65 - $260.95 $2.35 Million - $2.61 Million
10,000 Added 50.0%
30,000 $7.63 Million
Q1 2019

May 02, 2019

BUY
$180.87 - $203.88 $3.62 Million - $4.08 Million
20,000 New
20,000 $3.8 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Gabalex Capital Management LLC Portfolio

Follow Gabalex Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabalex Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabalex Capital Management LLC with notifications on news.